Clin Mol Hepatol.
2023 Apr;29(2):398-400. 10.3350/cmh.2023.0045.
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
- Affiliations
-
- 1Internal Medicine Department, Galilee Medical Center, Nahariya, Israel
- 2Rheumatology Unit, Galilee Medical Center, Nahariya, Israel
- 3Azrieli Faculty of Medicine in the Galilee, Bar-Ilan, University, Safed, Israel
- KMID: 2541427
- DOI: http://doi.org/10.3350/cmh.2023.0045
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diagnosis of Non-alcoholic Fatty Liver Disease
- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data
- Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
